verified
SJR 0,308 · Q3
•
database
Scopus / SJR & Web of Science indexed
United States · Mary Ann Liebert Inc.
workspace_premium
Q3 — Drug Discovery
lock
Subscription
Assay and Drug Development Technologies
Assay and Drug Development Technologies is a journal indexed in SJR in Drug Discovery and Molecular Medicine with an H index of 67. It has an SJR impact factor of 0,308 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,308.
Publisher: Mary Ann Liebert Inc.
Category: Drug Discovery
Indexation:
verifiedScopus / SJR
verifiedWeb of Science
open_in_new Portal NPD
menu_book Guidelines NPD
schedule
CountryOfPapers database fields
SJR Impact Factor
trending_up
0,308
Q3
H-index
67
Acceptance rate
pie_chart
29%
Selective
Source
Acceptance_Rate
Time to publication
hourglass_top
NPD
Field
NPD
Publication cost (APC)
payments
NPD
Subscription
Non-OA path
NPD
Metrics
Scimago and CountryOfPapers database fields
Scopus / SJR
Web of Science
SJR Impact
0,308
H-index
67
Docs (year)
33
Docs 3y
114
Total refs
2120
Cites 3y
186
Citable 3y
104
Cites/Doc 2y
1.55
Ref/Doc
64.24
Immediate OA
—
Embargoed OA
NPD
Non OA / Submission
—
shield
Researcher voice
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Fair & fast peer review
Clear APC / no surprise fees
Suspected predatory
Fake impact claims
Researcher reviews
sentiment_dissatisfied
No reviews yet — be the first to share an honest experience.